塔科苏博综合征的死亡风险分层:评估CRP测量与InterTAK预后得分一起进行评估
Loïc Faucher1, Kensuke Matsushita2,3, Shinnosuke Kikuchi2,3
1Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.
ESC heart failure
|January 17, 2025
概括
医院出院时持续的炎症预测了塔科苏博综合征的长期死亡率. 与InterTAK得分相结合,C-反应蛋白 (CRP) 水平改善了Takotsubo心肌病患者的风险分层.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 炎症 炎症是一种炎症.
背景情况:
- 最初被认为是良性的Takotsubo综合征与显著的死亡率有关.
- 肌心脏炎症可能是Takotsubo综合征的不良结果的基础.
- 现有的预后分数可能无法完全捕捉长期风险.
研究的目的:
- 评估C-反应蛋白 (CRP) 对塔科苏博综合征的长期死亡率的预后价值.
- 评估CRP是否提高了InterTAK预后得分的预测准确性.
- 确定出院时持续性炎症在塔科苏博综合征结局中的作用.
主要方法:
- 对307名塔科苏博综合征患者 (2008-2020年) 的回顾性分析.
- 根据InterTAK预后得分分层分为四分之一.
- 排放时C反应蛋白 (CRP) 水平的评估及其与1年全因死亡率的相关性.
主要成果:
- 在越来越多的InterTAK四分位数中观察到CRP水平的逐步增加.
- 出院时的CRP是1年死亡率 (AUC=0.81) 的重要预测指标,最佳值为33 mg/L.
- 结合CRP (≥33 mg/L) 显著改善了基于InterTAK得分的中间和非常高风险患者的1年死亡预测.
结论:
- 持续的炎症负担,如出院时CRP升高,是Takotsubo综合征1年死亡率的独立预测因素.
- 排放时的C反应蛋白 (CRP) 测量为InterTAK得分增加了显著的预后价值.
- 这一发现有助于完善风险分层,并可能指导塔科苏博综合征的管理.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
64
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64
01:30Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
110
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
110
01:28Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
01:19Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
3
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3